Cyclin D3 sensitizes tumor cells to tumor necrosis factor-induced, c- Myc-dependent apoptosis

Molecular and Cellular Biology

Volumn 16, Issue 10, 1996, Pages 5245-5253

  Jänicke, Reiner U ^a   Lin, Xiao Yu ^a   Lee, Fiona H H ^a   Porter, Alan G ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; DEXAMETHASONE; MYC PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ETIOLOGY; FIBROSARCOMA; HELA CELL; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

EID: 0141630973     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.10.5245     Document Type: Article

References (57)

1. Alexandrow, M. G., and H. L. Moses. 1995. Transforming growth factor β and cell cycle regulation. Cancer Res. 55:1452-1457.
2. Almasan, A., Y. Yin, R. E. Kelly, E. Y.-H. P. Lee, A. Bradley, W. Li, J. R. Bertino, and G. M. Wahl. 1995. Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsivc genes, and apoptosis. Proc. Natl. Acad. Sci. USA 92:5436-5440.
3. Amati, B., T. D. Littlewoud, G. I. Evan, and H. Land. 1993. The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J. 12:5083-5087.
4. Amin, C., A. J. Wagner, and N. Hay. 1993. Sequence-specific transcriptional activation by Myc and repression by Max. Mol. Cell. Biol. 13:383-390.
5. Belizario, J. E., and C. A. Dinarello. 1991. Interleukin 1, interleukin 6, tumor necrosis factor, and transforming growth factor β increase cell resistance to tumor necrosis factor cytotoxicity by growth arrest in the G1 phase of the cell cycle. Cancer Res. 51:2379-2385.
6. Beyaert, R., and W. Fiers. 1994. Molecular mechanisms of tumor necrosis factor-induced cytotoxicity. FEBS Lett. 340:9-16.
7. Bissonnette, R. P., A. McGahon, A. Mahboubi, and D. R. Green. 1994. Functional Myc-Max heterodimer is required for activation-induced apoptosis in T cell hybridomas. J. Exp. Med. 180:2413-2418.
8. Coffey, R. J., C. C. Bascom, N. J. Sipes, R. Graves-Deal, B. E. Weissman, and H. L. Moses. 1988. Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor beta. Mol. Cell. Biol. 8:3088-3093.
9. Daksis, J. I., R. Y. Lu, L. M. Facchini, W. W. Marhin, and L. J. Z. Penn. 1994. Myc induces cyclin D1 expression in the absence of de nova protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. Oncogene 9:3635-3645.
10. Darzynkiewicz, Z., B. Williamson, E. A. Carswell, and L. Old. 1984. Cell cycle-specific effects of tumor necrosis factor. Cancer Res. 44:83-90.
11. Dowdy, S., P. W. Hinds, K. Louie, S. I. Reed, A. Arnold, and R. A. Weinberg. 1993. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73:499-511.
12. Enari, M., H. Hug, and S. Nagata. 1995. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature (London) 375:78-83.
13. Evan, G. I., L. Brown, M. Whyte, and E. Harrington. 1995. Apoptosis and the cell cycle. Curr. Opin. Cell Biol. 7:825-834.
14. Evan, G. I., and T. D. Littlewood. 1993. The role of c-myc in cell growth. Curr. Opin. Genet. Dev. 3:44-49.
15. Ewen, M. E., H. K. Sluss, C. J. Sherr, H. Matsushime, J.-Y. Kato, and D. M. Livingston. 1993. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487-497.
16. Fotedar, R., J. Flatt, S. Gupta, R. L. Margolis, P. Fitzgerald, H. Messier, and A. Fotedar. 1995. Activation-induced T-cell death is cell cycle dependent and regulated by cyclin B. Mol. Cell. Biol. 15:932-942.
17. Freeman, R. S., S. Estus, and E. M. Johnson, Jr. 1994. Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of cyclin D1 during programmed cell death. Neuron 12:343-355.
18. Geng, Y., and R. A. Weinberg. 1993. Transforming growth factor βeffects on expression of G1 cyclins and cyclin-dependent protein kinases. Proc. Natl. Acad. Sci. USA 90:10315-10319.
19. Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044-1048.
20. Graña, X., and E. P. Reddy. 1995. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 11:211-219.
21. Haas-Kogan, D. A., S. C. Kogan, D. Levi, P. Dazin, A. T'Ang, Y.-K. T. Fung, and M. A. Israel. 1995. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J. 14:461-472.
22. Haupt, Y., S. Rowan, and M. Oren. 1995. p53-mediated apoptosis in HeLa cells can be overcome by excess pRb. Oncogene 10:1563-1571.
23. 2 is crucial in the cytotoxic action of tumor necrosis factor. J. Biol. Chem. 268:11290-11295.
24. Heald, R., M. McLoughlin, and F. McKeon. 1993. Human Wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated cdc2 kinase. Cell 74:463-474.
25. Hoang, A. T., K. J. Cohen, J. F. Barrett, D. A. Bergstrom, and C. V. Dang. 1994. Participation of cyclin A in Myc-induced apoptosis. Proc. Natl. Acad. Sci. USA 91:6875-6879.
26. Hunter, T., and J. Pines. 1994. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79:573-582.
27. Jänicke, R. U., F. H. H. Lee, and A. G. Porter. 1994. Nuclear c-Myc plays an important role in the cytotoxicity of tumor necrosis factor alpha in tumor cells. Mol. Cell. Biol. 14:5661-5670.
28. Jansen-Dürr, P., A. Meichle, P. Steiner, M. Pagano, K. Finke, J. Botz, J. Wessbecher, G. Draetta, and M. Eilers. 1993. Differential modulation of cyclin gene expression by MYC. Proc. Natl. Acad. Sci. USA 90:3685-3689.
29. Kato, G. J., J. Barrett, M. Villa-Garcia, and C. V. Dang. 1990. An amino-terminal c-myc domain required for neoplastic transformation activates transcription. Mol. Cell. Biol. 10:5914-5920.
30. Kato, J.-Y., H. Matsushime, S. W. Hiebert, M. E. Ewen, and C. J. Sherr. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7:331-342.
31. Kiess, M., R M. Gill, and P. A. Hamel. 1995. Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation of myoblasts into quiescent myotubes. Oncogene 10:159-166.
32. Klefstrom, J., I. Västrik, E. Saksela, J. Valle, M. Eilers, and K. Alitalo. 1994. c-Myc induces cellular susceptibility to the cytotoxic action of TNF-α. EMBO J. 13:5442-5450.
33. Kranenburg, O., A. J. van der Eb, and A. Zantema. 1996. Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J. 15:46-54.
34. Kretzner, L., E. M. Blackwood, and R. N. Eisenman. 1992. Myc and Max proteins possess distinct transcriptional activities. Nature (London) 359:426-429.
35. Kumar, S., and C. Baglioni. 1991. Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2. J. Biol. Chem. 266:20960-20964.
36. Lee, S., S. Christakos, and M. B. Small. 1993. Apoptosis and signal transduction: clues to a molecular mechanism. Curr. Opin. Cell. Biol. 5:286-291.
37. Lee, T.-C., V. Zhang, and R. J. Schwartz. 1994. Bifunctional transcriptional properties of YY1 in regulating muscle actin and c-myc gene expression during myogenesis. Oncogene 9:1047-1052.
38. Manu, K. B., S. A. Bossone, and A. J. Patel. 1992. Myc function and regulation. Annu. Rev. Biochem. 61:809-860.
39. Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J.-Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066-2076.
40. Meikrantz, W., S. Gisselbrecht, S. W. Tam, and R. Schlegel. 1994. Activation of cyclin A-dependent protein kinases during apoptosis. Proc. Natl. Acad. Sci. USA 91:3754-3758.
41. 1/S-phase boundary is suppressed by inhibitory c-Myc mutants. Mol. Cell. Biol. 15:2527-2535.
42. Münger, K., J. A. Pietenpol, M. R. Pittelkow, J. T. Holt, and H. L. Moses. 1992. Transforming growth factor beta 1 regulation of c-myc expression, pRb phosphorylation, and cell cycle progression in keratinocytes. Cell Growth Differ. 3:291-298.
43. Philipp, A., A. Schneider, I. Väsrik, K. Finke, Y. Xiong, D. Beach, K. Alitalo, and M. Eilers. 1994. Repression of cyclin D1: a novel function of MYC. Mol. Cell. Biol. 14:4032-4043.
44. Pietenpol, J. A., R. W. Stein, E. Moran, P. Yaciuk, R. Schlegel, R. M. Lyons, M. R. Pittelkow, K. Münger, P. M. Howely, and H. L. Moses. 1990. TGFβ-1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRb binding domains. Cell 61:777-785.
45. Qin, X-Q., D. M. Livingston, W. G. Kaelin, Jr., and P. D. Adams, 1994. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91:10918-10922.
46. Quelle, D. E., R. A. Ashmun, S. A. Shurtleff, J.-Y. Kato, D. Bar-Sagi, M. F. Roussel, and C. J. Sherr. 1993. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev. 7:1559-1571.
47. Rao, S. S., and D. S. Kohtz. 1995. Positive and negative regulation of D-type cyclin expression in skeletal myoblasts by basic fibroblast growth factor and transforming growth factor beta. A role for cyclin D1 in control of myoblast differentiation. J. Biol. Chem. 270:4093-4100.
48. Reid, T. R., F. M. Torti, and G. M. Ringold. 1989. Evidence for two mechanisms by which tumor necrosis factor kills cells. J. Biol. Chem. 264:4583-4589.
49. Riggs, K. J., S. Saleque, K.-K. Wong, K. T. Merrell, J.-S. Lee, Y. Shi, and K. Calame. 1993. Yin-Yang 1 activates the c-myc promoter. Mol. Cell. Biol. 13:7487-7495.
50. Schwarz, J. K., C. H. Bassing, I. Kovesdi, M. B. Datto, M. Blazing, S. George, X. F. Wang, and J. R. Nevins. 1995. Expression of the E2F1 transcription factor overcomes type beta transforming growth factor-mediated growth suppression. Proc. Natl. Acad. Sci. USA 92:483-487.
51. Shan, B., and W.-H. Lee. 1994. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 14:8166-8173.
52. cdc2 activation required for apoptosis. Science 263:1143-1145.
53. Shimizu, T., P. M. O'Connor, K. W. Kohn, and Y. Pommier. 1995. Unscheduled activation of cyclin B1/Cdc2 kinase in human promyelocytic leukemia cell line HL60 cells undergoing apoptosis induced by DNA damage. Cancer Res. 55:228-231.
54. Stone, J., T. de Lange, G. Ramsey, E. Jakobovits, J. M. Bishop, H. Varmus, and W. Lee. 1987. Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol. Cell. Biol. 7:1697-1709.
55. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
56. Wu, X., and A. J. Levine. 1994. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91:3602-3606.
57. Zheng, X. M., Y. Wang, and C. J. Pallen. 1992. Cell transformation and activation of pp60c-src by overexpression of a protein tyrosine phosphatase. Nature (London) 359:335-339.